Minimal change disease associated with newly diagnosed mantle cell lymphoma

Mantle cell lymphoma (MCL) is a rare but aggressive form of non-Hodgkin's lymphoma. Involvement of the kidney is an infrequent occurrence in patients with MCL and can be the result of direct infiltration or paraneoplastic glomerulopathy. Proliferative glomerulonephritis, membranoproliferative g...

Full description

Saved in:
Bibliographic Details
Published inRenal Failure Vol. 36; no. 4; pp. 634 - 637
Main Authors Khow, Kareeann S. F., Yong, Angelina S. M., Yong, Tuck Y., Kuss, Bryone J., Barbara, Jeffrey A. J., Li, Jordan Y. Z.
Format Report
LanguageEnglish
Published Taylor & Francis 01.05.2014
Subjects
Mantle cell lymphoma
minimal change disease
nephrotic syndrome
paraneoplastic glomerulopathy
Online AccessGet full text

Cover

More Information
Summary:Mantle cell lymphoma (MCL) is a rare but aggressive form of non-Hodgkin's lymphoma. Involvement of the kidney is an infrequent occurrence in patients with MCL and can be the result of direct infiltration or paraneoplastic glomerulopathy. Proliferative glomerulonephritis, membranoproliferative glomerulonephritis and focal segmental glomerulosclerosis have previously been reported in association with MCL. We report a 55-year-old woman who developed nephrotic syndrome due to biopsy proven minimal change disease (MCD) in association with MCL. Proteinuria decreased with prednisolone treatment and MCD remains in remission without any immunosuppressant after the treatment of the underlying MCL.
ISSN:0886-022X
1525-6049
DOI:10.3109/0886022X.2014.883905